This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
“What’s Next for GenAI in Business” panel at last week’s Big.AI@MIT Unfortunately, despite hard-earned lessons around what works and what doesn’t, pressure-tested reference architectures for gen AI — what IT executives want most — remain few and far between, she said.
It prevents vendor lock-in, gives a lever for strong negotiation, enables business flexibility in strategy execution owing to complicated architecture or regional limitations in terms of security and legal compliance if and when they rise and promotes portability from an application architecture perspective.
The CAFs purpose is to test, challenge and support the art and science of Business Technology Architecture and its evolution over time as well as grow the influence and leadership of chief architects both inside and outside the profession. This article was made possible by our partnership with the IASA Chief Architect Forum.
The giant pharmaceutical chain had put its lakehouse in place to address just such challenges in its quest, to, as Guadagno puts it, “To get the right product in the right place for the right patient.”. Using Apache Ignite technology from GridGain, Wiesenfeld created an in-memory computing architecture.
The Royal Pharmaceutical Society announced that it has appointed Avril Chester as its new Chief Technology Officer. In her new role, Avril will have “responsibility for executive leadership of all the technology functions, including technical architecture, software development, operations and product delivery.” March 2022.
The data architect also “provides a standard common business vocabulary, expresses strategic requirements, outlines high-level integrated designs to meet those requirements, and aligns with enterprise strategy and related businessarchitecture,” according to DAMA International’s Data Management Body of Knowledge.
One of the biggest things I’ve learned is you can’t do automation to the business; you have to do it with the business.” In general, it’s been straight forward to quantify the business impact of automation initiatives, given they typically have clear before and after business metrics.
Caveat emptor in the cloud Bob McGowan, CIO of Regeneron Pharmaceuticals, acknowledges the risk of cloud concentration is valid but he is more concerned about the readiness of SaaS partners. “If Here is a look at how CIOs view the nature and nuances of cloud concentration risks — and what many are doing to mitigate them.
Then in 2006 Nvidia introduced a new GPU architecture, CUDA, that could be programmed directly in C to accelerate mathematical processing, simplifying its use in parallel computing. It’s also in the service business, operating its own cloud infrastructure for pharmaceutical firms, manufacturing, and others.
In a pharmaceutical company, AI can accelerate drug development through the identification of key proteins, or turbocharge drug design by speeding up the ability to generate complex molecular structures. Virtually every vendor or service provider is looking for ways to build gen AI into their solutions.
Serving leaders in the energy, fashion, financial services, food, healthcare, manufacturing, media, pharmaceutical, professional services, retail, and telecommunications industries, WIIT works with organizations that have stringent business continuity needs, mission-critical applications, and crucial data security and sovereignty requirements.
But he also notes that there will be innovations within the data center itself — in the GPUs and agile architecture — to pinpoint and address consumption needs. “AI Additional innovation with respect to distributed AI architectures is also on the horizon.
We’ve established an AI working group with representatives across technology, architecture, data, security, legal, risk, and audit consisting of both technical practitioners and business users to develop AI-use best practices and a governance framework,” says Nafde. “On-time delivery has improved substantially,” she says.
Initially building a scalable app may look expensive but changing the complete architecture later will incur more cost,” he says. Anjani Kumar, CIO at pharmaceutical company Strides, says agile offers the flexibility to break down a project into various small parts, which are delivered through cycles or iterations.
The multicloud calculus Mojgan Lefebvre, EVP and chief technology and operations officer at Travelers, says a multicloud architecture not only offers enterprises the freedom to use best-of-breed cloud services but also the ability to negotiate better financial terms from each cloud provider.
Managing inventory, both pre-operative and post-operative, is time consuming because the inventory replenishment process is reactive,” says Jim Swanson, CIO at US pharmaceutical and medical technologies company Johnson & Johnson. As an example, Swanson points to total knee arthroplasty (TKA) and total hip arthroplasty (THA) procedures.
In pharmaceutical R&D, the Pangu drug molecule model has drastically shortened lead compound discovery cycles from years to a single month, while achieving a 70% reduction of costs. Consider how the Pangu model was able to predict a 10-day typhoon trajectory in 10 seconds against five hours using current methods.
Nvidia is targeting it at pharmaceutical firms for drug discovery and testing, fine-tuning it with proprietary data. Having Nvidia as a service provider will likely mean a single source of responsibility for the service and a familiar underlying solution architecture,” he said.
When assessing vendors, Rich Products looks at their technology, architecture, business value, and pragmatic perspective. The goal, he says, is to understand how AI will benefit Rich’s business overall. “We We look at the vendor’s maturity and if they have proven success in the right focus areas for our business,” he says. “But
In his new role, Ramamoorthy will lead technology and digital transformation for the bank, as well as be responsible for modern technologies such as APIs, AI and machine learning, and businessintelligence. Bhavesh Gandhi has been appointed as chief digital and information officer at chemical and pharmaceutical major Aarti Industries.
Or of formulas and know-how and trade secrets at pharmaceutical and biotech companies. For a large enterprise architecture, we need a control plane and a data plane, and we need to separate the control plane from the data plane. Think about IP in terms of chemical formulas at consumer-packaged goods or chemicals companies.
Taking risks with emerging, cutting-edge technologies is another approach of many digital businesses. This is what Zuellig Pharma did which it to becoming the recipient of the Best in Future of Intelligence and Special Award for Digital Resiliency in 2022. CIO, Enterprise Applications, Enterprise Architecture
Other industries using Amazon EC2 for HPC-style workloads include pharmaceuticals, oil exploration, industrial and automotive design, media and entertainment, and more. They have run thousands of instances of complex Monte Carlo simulations at night to determine how to be ready at market open. until today.
For example, one pharmaceutical company using ChatGPT4 or similar for corporate espionage could essentially spy on its competitor’s research queries. One Fortune 500 executive recently told me that they were worried that one organization could use a public LLM to learn what its competitors were asking that same LLM.
So CIO Brad Miller along with head of AI engineering Andrew Giessel and others opted to create an alpha application using OpenAI’s backend API, with a zero data retention architecture to protect the company’s data. It then built a cutting-edge cloud-based analytics platform, designed with an innovative data architecture.
Pilots often reveal the feasibility of scaling; however, not all initiatives will make business sense to expand. It’s crucial to design a sustainable architecture with the end goal in mind, ensuring scalability aligns with business objectives. Leaders should view data quality as a strategic asset.
We organize all of the trending information in your field so you don't have to. Join 83,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content